Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 49 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
APOTHEEK HANDZAME from Kortemark, company number BE0844661251, closed financial year 2025 with a result of € 44,611 after tax. For that financial year APOTHEEK HANDZAME recorded a gross margin of € 168,726 and equity of € 52,044. Compared with financial year 2024, the result moved from € 13,942 to € 44,611. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
€ 52,044
▲ 116% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 44,611
▲ 220% vs 2024
Profit after tax over the fiscal year.
€ 46,875
▲ € 36,741 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 16,666 paid out
37 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 89,855
▼ 19% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,782
▼ 55% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 3,385
▼ 54% vs 2024
Loans from banks and other lenders, long and short.
€ 64,747
▲ 9% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 24,621
▼ 32% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 164,539 | € 102,657 | € 148,260 | € 168,726 | ▲ 14% |
| Profit after taxes | € 34,077 | € -37,544 | € 13,942 | € 44,611 | ▲ 220% |
| Equity | € 47,700 | € 10,157 | € 24,098 | € 52,044 | ▲ 116% |
| Total debts | € 348,636 | € 291,879 | € 276,427 | € 292,336 | ▲ 6% |
| Cash | € 94,678 | € 13,779 | € 10,134 | € 46,875 | ▲ € 36,741 |
| Retained profit | € 41,500 | € 3,957 | € 17,898 | € 45,844 | ▲ 156% |
| Dividend | € 7,800 | € 0 | € 0 | € 16,666 | |
| Bank debt | € 30,377 | € 26,745 | € 7,416 | € 3,385 | ▼ 54% |
| Balance sheet total | € 396,337 | € 302,036 | € 300,525 | € 344,380 | ▲ 15% |
| Employees (FTE) | - | 1.4 | 1.3 | - |
Key figures of APOTHEEK HANDZAME, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK HANDZAME?
What happened at APOTHEEK HANDZAME in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 44,611 (▲ 220% vs 2024). Source: NBB ↗
- Kim Rebry became a director. NBB
- New establishment in Kortemark. KBO
- Start of the company according to the CBE. KBO
- Jeroen Goddeeris became a director. NBB
In short
From € 34,077 profit in 2022 to € 44,611 profit in 2025.
Paid € 31,188 in corporate taxes since 2022.
Best year ever: 2025, with € 44,611 profit.
On average € 114,000 of value added per employee in 2024.
A new publication or filing at APOTHEEK HANDZAME? We notify you, reason included.
Follow APOTHEEK HANDZAMEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind APOTHEEK HANDZAME are Jeroen Goddeeris and Kim Rebry.
Directors
According to the 2025 annual accounts
Jeroen Goddeeris
Director
since 2012
Kim Rebry
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Handzameplein 30
8610 Kortemark
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0844.661.251
- VAT number
- BE 0844.661.251
- Registered office
- Handzameplein 30, 8610 Kortemark
- Names & denominations
- APOTHEEK HANDZAME
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 March 2012
- Peppol
- Active · Active since 23 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten